Depomed (DEPO) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q4 EPS of $0.48, $0.12 better than the analyst estimate of $0.36. Revenue for the quarter came in at $123.9 million versus the consensus estimate of $123.28 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
